Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-29

FDA Approved: TRETINOIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approves Glenmark's supplemental application for tretinoin (all-trans retinoic acid), updating the product's regulatory status per the submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRETINOIN (TRETINOIN)

Snippet

SUPPL AP for TRETINOIN (TRETINOIN)